title: Gene-environment interaction between MBL2 genotype and smoking, and the risk of gram-positive bacteraemia.
abstract: Mannose-binding lectin (MBL) insufficiency caused by point mutations in the MBL2 gene has been associated with increased susceptibility to bacteraemic infections. We here investigated the effect of MBL2 polymorphisms on the susceptibility and clinical course of bacteraemia. The study cohort comprised 145 patients with bacteraemia and 400 controls. In the case of patients with bacteraemia, laboratory findings and clinical data were registered on admission and during six consecutive days. MBL2 structural polymorphisms at codons 52 (CGT-->TGT; designated D or O), 54 (GGC-->GAC; B or O) and 57 (GGA-->GAA; C or O) in exon 1 of the MBL2 gene and promoter region polymorphisms at position -221 (G-->C, designated Y or X alleles) were determined. No difference in MBL2 genotype frequencies between the bacteraemic patients and controls was detected, and MBL2 genotype had no independent effect on mortality, nor disease severity. However, smoking proved a significant risk factor for Gram-positive (Staphylococcus aureus, Streptococcus pneumoniae or beta-haemolytic streptococci) bacteraemia in patients carrying the variant O allele (53% current smokers in Gram-positive bacteraemia patients compared with only 21% in controls, odds ratios 4.2, 95% confidence intervals 2.0-9.0; P < 0.001), while it did not have an effect in those homozygous for the A allele. The same effect was not detected in Escherichia coli bacteraemia. In conclusion, MBL2 genotypes representing MBL insufficiency were not associated with the overall risk of bacteraemia or disease severity, but smoking in carriers of the structural variant O allele may have a deleterious effect increasing the risk of Gram-positive bacteraemia.
authors.affiliation: Department of Internal Medicine, Tampere University Hospital, Tampere, Finland. reetta.huttunen@uta.fi
authors.forename: R
authors.initials: R
authors.lastname: Huttunen
authors.forename: J
authors.initials: J
authors.lastname: Aittoniemi
authors.forename: J
authors.initials: J
authors.lastname: Laine
authors.forename: R
authors.initials: R
authors.lastname: Vuento
authors.forename: J
authors.initials: J
authors.lastname: Karjalainen
authors.forename: A T
authors.initials: AT
authors.lastname: Rovio
authors.forename: C
authors.initials: C
authors.lastname: Eklund
authors.forename: M
authors.initials: M
authors.lastname: Hurme
authors.forename: H
authors.initials: H
authors.lastname: Huhtala
authors.forename: J
authors.initials: J
authors.lastname: Syrjänen
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D016470:Bacteremia / Q000235:genetics*; D005260:Female; D020022:Genetic Predisposition to Disease; D005838:Genotype; D016908:Gram-Positive Bacterial Infections / Q000235:genetics*; D006801:Humans; D008297:Male; D037601:Mannose-Binding Lectin / Q000235:genetics*; D008875:Middle Aged; D011401:Promoter Regions, Genetic / Q000235:genetics; D012307:Risk Factors; D012907:Smoking / Q000009:adverse effects*
chemical_list: C445619:MBL2 protein, human; D037601:Mannose-Binding Lectin